(Q37810251)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Peter H. Roos

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Peter H Roos

series ordinal

1

1 reference

23 August 2017

publication date

1 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

295-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of urinary bladder cancer: from tumor development to patient's death

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Survivin: a promising biomarker for detection and prognosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Urinary markers in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Potential of urinary biomarkers in early bladder cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

p53 and retinoblastoma pathways in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Molecular biology of bladder cancer: prognostic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Molecular alterations associated with bladder cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Discovery of urinary biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Novel blood biomarkers of human urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Serum proteomic profiling in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Practical points in urinary proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Should urine pH be adjusted prior to gel-based proteome analysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Are protease inhibitors required for gel-based proteomics of kidney and urine?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Sample handling for mass spectrometric proteomic investigations of human sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Proteomics approaches to urologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Strategies for revealing lower abundance proteins in two-dimensional protein maps.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Proteome profile of human urine with two-dimensional liquid phase fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Protein profiling in urine for the diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Urinary biomarker profiling in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

ProteinChip technology reveals distinctive protein expression profiles in the urine of bladder cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Isolation and identification of potential urinary microparticle biomarkers of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Profiling bladder cancer using targeted antibody arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Molecular pathogenesis and diagnostics of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Impact of RNA degradation on gene expression profiles: assessment of different methods to reliably determine RNA quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Single base pair mutation analysis by PNA directed PCR clamping

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Epigenetic changes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Epigenetic biomarkers in urothelial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Epigenetic markers as promising prognosticators for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

The MIRA method for DNA methylation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Sensitive detection of FGFR3 mutations in bladder cancer and urine sediments by peptide nucleic acid-mediated real-time PCR clamping

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Detection of circulating tumor cells in bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Detection and isolation of circulating tumor cells in urologic cancers: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Differentiation of epithelial cells in the urinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Uroplakins in urothelial biology, function, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Mining the tumor phosphoproteome for cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Enrichment of multiphosphorylated peptides by immobilized metal affinity chromatography using Ga(III)- and Fe(III)-complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

A phosphotyrosine-imprinted polymer receptor for the recognition of tyrosine phosphorylated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Single cell profiling of potentiated phospho-protein networks in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

High-content single-cell drug screening with phosphospecific flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Simple, fast and high-throughput single-cell analysis on PDMS microfluidic chips

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

A novel permalloy based magnetic single cell micro array

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Concomitant detection of CYP1A1 enzymatic activity and CYP1A1 protein in individual cells of a human urothelial cell line using a bilayer microfluidic device.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Imaging individual microRNAs in single mammalian cells in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Predicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.09.174

21 January 2018

Identifiers

DOI

10.4155/BIO.09.174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21083311%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference